| Quebec Pancreas Cancer Study (NCT04104230) | George Zogopoulos | 2012-03-12 |
| Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy (NCT01938716) | M.D. Anderson Cancer Center | 2012-03-01 |
| Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients (NCT01487785) | Novartis Pharmaceuticals | 2012-03-01 |
| A Study Using 18F-FAZA and PET Scans to Study Hypoxia in Pancreatic Cancer (NCT01542177) | University Health Network, Toronto | 2012-02-01 |
| Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas (NCT01438476) | M.D. Anderson Cancer Center | 2012-01-26 |
| FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer (NCT01688336) | UNC Lineberger Comprehensive Cancer Center | 2012-01-01 |
| Pilot Study of Meat-Borne Carcinogens and Pancreatic Cancer (NCT01492907) | University of Minnesota | 2012-01-01 |
| A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer (NCT01986738) | University of Michigan Rogel Cancer Center | 2012-01-01 |
| A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands (NCT01351103) | Novartis Pharmaceuticals | 2011-12-01 |
| A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer (NCT01505530) | Eli Lilly and Company | 2011-12-01 |
| LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer (NCT01485744) | Massachusetts General Hospital | 2011-12-01 |
| Slide Interpretation or Standard Surgical Pathology in Assessing Margin Status in Patients With Pancreatic Cancer Undergoing Surgery (NCT01646697) | Ohio State University Comprehensive Cancer Center | 2011-11-07 |
| Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer (NCT01458717) | Seoul National University Hospital | 2011-11-01 |
| Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer (NCT01459614) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-11-01 |
| A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma (NCT01472198) | Gilead Sciences | 2011-11-01 |
| T-EUS for Gastrointestinal Disorders: A Multicenter Registry (NCT01522573) | Weill Medical College of Cornell University | 2011-11-01 |
| Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma (NCT01601808) | University of Liverpool | 2011-10-10 |
| Double Bypass Versus Stent-treatment in Irresectable Pancreatic Cancer (NCT01569282) | Göteborg University | 2011-10-01 |
| Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects (NCT01450046) | H. Lee Moffitt Cancer Center and Research Institute | 2011-10-01 |
| Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer (NCT01553019) | University of Florida | 2011-10-01 |
| Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer (NCT01523457) | Yale University | 2011-10-01 |
| Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma (NCT01470417) | University of Florida | 2011-10-01 |
| Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP) (NCT01587534) | National Cancer Center, Korea | 2011-10-01 |
| Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia (NCT01444456) | Amgen | 2011-10-01 |
| Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects (NCT01446952) | H. Lee Moffitt Cancer Center and Research Institute | 2011-09-01 |
| A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers (NCT01521325) | Morphotek | 2011-09-01 |
| FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma (NCT01383538) | Andrew Ko | 2011-08-23 |
| Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer) (NCT01420874) | Barbara Ann Karmanos Cancer Institute | 2011-08-17 |
| Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer (NCT01335945) | Boston Scientific Corporation | 2011-08-01 |
| Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors (NCT01929720) | Ohio State University Comprehensive Cancer Center | 2011-08-01 |
| ABC294640 in Treating Patients With Advanced Solid Tumors (NCT01488513) | RedHill Biopharma Limited | 2011-08-01 |
| Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma (NCT01360593) | David A. Clump, MD, PhD | 2011-07-25 |
| Study of Ruxolitinib in Pancreatic Cancer Patients (NCT01423604) | Incyte Corporation | 2011-07-01 |
| A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers (NCT01661114) | University of Michigan Rogel Cancer Center | 2011-07-01 |
| Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders (NCT01438385) | Weill Medical College of Cornell University | 2011-07-01 |
| CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors (NCT01386502) | National Cancer Institute (NCI) | 2011-06-15 |
| Valproic Acid With Chemoradiotherapy for Pancreatic Cancer (NCT01333631) | Soroka University Medical Center | 2011-06-01 |
| A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients (NCT01661088) | University of Michigan Rogel Cancer Center | 2011-06-01 |
| Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer (NCT01327794) | Alliance for Clinical Trials in Oncology | 2011-06-01 |
| SOM 230 and Gemcitabine in Advanced Pancreatic Cancer (NCT01385956) | H. Lee Moffitt Cancer Center and Research Institute | 2011-06-01 |
| Trial Assessing Roux-en-Y Anastomosis of the Pancreatic Stump to Prevent Pancreatic Fistula Following Distal Pancreatectomy (NCT01384617) | Wakayama Medical University | 2011-06-01 |
| A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer (NCT01373164) | Eli Lilly and Company | 2011-06-01 |
| Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer (NCT01395017) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2011-06-01 |
| Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery (NCT01416662) | Federation Francophone de Cancerologie Digestive | 2011-06-01 |
| On-site Cytopathology EUS-FNA (NCT01386931) | University of Colorado, Denver | 2011-06-01 |
| Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies (NCT01401907) | Massachusetts General Hospital | 2011-05-01 |
| QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas (NCT01231347) | NantCell, Inc. | 2011-04-07 |
| Chemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable Tumours (NCT01397019) | Per Pfeiffer | 2011-04-01 |
| Biospecimens for Identification of Diseases of the Pancreas. (NCT01392027) | University of Michigan | 2011-04-01 |
| Pancreaticogastrostomy Versus Pancreaticojejunostomy in Reconstruction After Cephalic Duodenopancreatectomy (NCT01324856) | University of Belgrade | 2011-04-01 |
| New Treatment Option for Pancreatic Cancer (NCT01364805) | Jeanne Drisko, MD, CNS, FACN | 2011-04-01 |
| EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer (NCT02209415) | Michael Bau Mortensen | 2011-04-01 |
| HYPAZ: Hypertension Induced by Pazopanib (NCT01392352) | Cambridge University Hospitals NHS Foundation Trust | 2011-04-01 |
| PET-CT in Diagnosis of Pancreatic Cystic Neoplasms (NCT01317836) | Turku University Hospital | 2011-03-01 |
| Trabectedin in Treating Patients With Metastatic Pancreatic Cancer After First-Line Chemotherapy (NCT01339754) | IRCCS San Raffaele | 2011-02-01 |
| Multimodal Therapy Impact on Pancreatic Cancer Survival (NCT06938906) | National Cheng Kung University | 2011-01-03 |
| Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic Cancer (NCT01505413) | Soonchunhyang University Hospital | 2011-01-01 |
| Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer (NCT01273805) | Dana-Farber Cancer Institute | 2011-01-01 |
| Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Non-operable Adenocarcinoma of the Pancreas (NCT01188785) | Silenseed Ltd | 2011-01-01 |
| Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas (NCT01276613) | M.D. Anderson Cancer Center | 2011-01-01 |
| Endoscopic Ultrasound-guided Biliary Drainage for Malignant Biliary Obstruction After Failed ERCP (NCT03510754) | Azienda USL Reggio Emilia - IRCCS | 2011-01-01 |
| Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer (NCT01296763) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-01-01 |
| Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer (NCT01442974) | Grupo Hospital de Madrid | 2011-01-01 |
| A Comparative Clinical Research on Single Roux-en-Y and Traditional Roux-en-Y of Pancreaticojejunostomy-choledochojejunostomy For Treatment of Obstruction of Pancreatic Duct and Bile Duct (NCT01926717) | Chengyi Sun | 2010-12-01 |
| A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas (NCT01240304) | University of Arkansas | 2010-11-01 |
| Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas (NCT01128296) | Amer Zureikat | 2010-10-01 |
| Perception Prognosis, Goals of Treatment, and Communication (NCT01401894) | Massachusetts General Hospital | 2010-10-01 |
| Study of Intratumoral Hypoxia Using Pre-operative Administration of Pimonidazole (NCT01248637) | University Health Network, Toronto | 2010-10-01 |
| Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy (NCT01056601) | Masonic Cancer Center, University of Minnesota | 2010-09-01 |
| Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer (NCT01304160) | Centre hospitalier de l'Université de Montréal (CHUM) | 2010-09-01 |
| Trial of Ascertaining Individual Preferences for Loved One's Role in End-of-Life (NCT01160367) | Johns Hopkins University | 2010-08-26 |
| Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer (NCT01333332) | University of Virginia | 2010-08-01 |
| A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer (NCT01189929) | OncoMed Pharmaceuticals, Inc. | 2010-08-01 |
| Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure (NCT01219192) | Protgen Ltd | 2010-08-01 |
| Gem-TABS in Unresectable Pancreatic Carcinoma (NCT01198821) | H. Lee Moffitt Cancer Center and Research Institute | 2010-08-01 |
| Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer (NCT01080248) | Washington University School of Medicine | 2010-08-01 |
| Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic Cancer (NCT01175733) | Amsterdam UMC, location VUmc | 2010-07-08 |
| SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer (NCT01811277) | Peking University | 2010-07-01 |
| Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer (NCT01167738) | IRCCS San Raffaele | 2010-07-01 |
| A Phase 2 Study of Pertuzumab and Erlotinib for Refractory Pancreatic Adenocarcinoma (NCT01108458) | George Albert Fisher | 2010-07-01 |
| Phase I Trial of 5-Azacitidine Plus Gemcitabine in Patients With Advanced Pancreatic Cancer (NCT01167816) | University of Oklahoma | 2010-07-01 |
| Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment Decision (NCT01188109) | Emory University | 2010-07-01 |
| Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma (NCT01161186) | University of California, San Francisco | 2010-07-01 |
| Comparison of Metal and Plastic Stents for Preoperative Biliary Decompression (NCT01191814) | AdventHealth | 2010-07-01 |
| Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic Cancer (NCT01015820) | Mayo Clinic | 2010-06-01 |
| Cancer in Patients With Gabapentin (GPRD) (NCT01236053) | GlaxoSmithKline | 2010-06-01 |
| Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer (NCT01218880) | Protgen Ltd | 2010-06-01 |
| Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer (NCT01150630) | IRCCS San Raffaele | 2010-05-01 |
| Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage (NCT01132755) | Memorial Sloan Kettering Cancer Center | 2010-05-01 |
| A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer (NCT01025570) | University of California, San Francisco | 2010-05-01 |
| A Pilot Study to Evaluate the Efficacy and Safety of Neoadjuvant Chemoradiotherapy With Capecitabine, . . . (NCT01130701) | University of Massachusetts, Worcester | 2010-05-01 |
| Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer (NCT01088789) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2010-04-20 |
| Secretin-enhanced Magnetic Resonance Imaging (S-MRI) for Pancreatic Cancer Detection (NCT01094626) | Elizabeth Hecht | 2010-04-01 |
| Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic Cancer (NCT01186731) | INSYS Therapeutics Inc | 2010-04-01 |
| Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients (NCT00966277) | M.D. Anderson Cancer Center | 2010-04-01 |
| MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery (NCT01098344) | Cancer Research UK | 2010-04-01 |
| Immunotherapy Study for Surgically Resected Pancreatic Cancer (NCT01072981) | NewLink Genetics Corporation | 2010-04-01 |
| Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) in the Management of Unresectable Bile Duct and Pancreatic Cancer (NCT01303159) | Weill Medical College of Cornell University | 2010-03-01 |
| Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD) (NCT01138124) | GlaxoSmithKline | 2010-03-01 |
| Comparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic Cancer (NCT01362582) | National Center for Tumor Diseases, Heidelberg | 2010-03-01 |